Vascular Biology Program, Children's Hospital Boston, Boston, MA 02115, USA.
Biol Reprod. 2011 Aug;85(2):261-8. doi: 10.1095/biolreprod.110.086645. Epub 2011 Apr 13.
The development and demise of the corpus luteum (CL) are accompanied by angiogenic and angioregressive processes; however, the mediators of these processes have not been fully identified and characterized. Transcriptional profiling studies revealed the upregulation of cysteine-rich 61 (CYR61) in the CL, about which nothing was previously known. In the present study, we found that over a 12-h period following a single injection of prostaglandin F(2alpha) (PGF(2alpha)), RT-PCR revealed the upregulation of CYR61 at 0.5 and 1 h, after which it declined. We also determined that luteal-derived endothelial cells as well as luteal steroidogenic cells are sources of CYR61. Treatment with PGF(2alpha) in vitro had no effect on CYR61 expression in luteal-derived endothelial cells, but it increased CYR61 expression in luteal steroidogenic cells. During the estrous cycle, CYR61/CYR61 (transcript/protein) was increased in the Day 4 but not in the Day 10 and Day 16 CL, suggesting that it may be associated with the switch to the angiogenic phenotype. In addition, the specific but transient upregulation of CYR61 by PGF(2alpha) in vivo, and in luteal steroidogenic cells but not endothelial cells in vitro, may be part of the mechanism underlying the previously reported transient increase in blood flow during the early onset of luteolysis. This is supported by our preliminary finding that CYR61 transiently inhibited endothelial cell expression of endothelin-converting enzyme 1 mRNA but not endothelin 1. Collectively, the increased expression of CYR61 in the Day 4 CL and its transient increase by PGF(2alpha) in Day 6, Day 10, and Day 16 CL indicate that CYR61 may play a role in regulating angiogenesis over the life span of the CL.
黄体(CL)的发育和退化伴随着血管生成和血管退化过程;然而,这些过程的介质尚未完全确定和表征。转录谱研究显示,胱氨酸丰富 61(CYR61)在黄体中上调,对此以前一无所知。在本研究中,我们发现,在单次注射前列腺素 F(2alpha)(PGF(2alpha))后的 12 小时内,RT-PCR 显示 CYR61 在 0.5 和 1 小时上调,之后下降。我们还确定黄体衍生的内皮细胞以及黄体甾体生成细胞是 CYR61 的来源。体外用 PGF(2alpha)处理对黄体衍生的内皮细胞中的 CYR61 表达没有影响,但增加了黄体甾体生成细胞中的 CYR61 表达。在发情周期中,CYR61/CYR61(转录本/蛋白)在第 4 天增加,但在第 10 天和第 16 天的黄体中没有增加,这表明它可能与向血管生成表型的转变有关。此外,PGF(2alpha)在体内以及在黄体甾体生成细胞中但不在内皮细胞中对 CYR61 的特异性但短暂上调,可能是先前报道的黄体溶解早期血流短暂增加的机制的一部分。这得到了我们的初步发现的支持,即 CYR61 短暂抑制内皮细胞内皮素转换酶 1 mRNA 的表达,但不抑制内皮素 1。总的来说,第 4 天黄体中 CYR61 的表达增加及其在第 6、10 和 16 天黄体中短暂增加表明,CYR61 可能在黄体寿命内发挥调节血管生成的作用。